Trial Profile
Rosuvastatin versus atorvastatin following PCI in patients also receiving clopidogrel
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Mar 2011
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Atorvastatin; Rosuvastatin
- Indications Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics; Pharmacogenomic
- 08 Mar 2011 New trial record